Yoko Yamaguchi of Nanoegg Wins Forbes JAPAN and EY Awards 2025

Yoko Yamaguchi of Nanoegg Receives Prestigious Awards

Yoko Yamaguchi, the CEO of Nanoegg, has recently been awarded both the Forbes JAPAN WOMEN AWARD 2025 and the EY Winning Women 2025. This recognition marks a significant achievement in her remarkable journey from a physicist to a pharmaceutical researcher and eventually a venture entrepreneur.

Initially, Yamaguchi dedicated herself to the field of physics, conducting extensive research. However, her career path took a transformative turn when her daughter suffered from atopic dermatitis, which motivated her to shift her focus to the medical sector. After joining St. Marianna University of Medicine as an assistant researcher, her dedication and expertise led to her promotion to associate professor, where she specialized in dermatology and drug delivery systems (DDS).

In 2006, driven by her desire to contribute to society through scientific advancements, Yamaguchi founded Nanoegg, a venture based on the university’s research. Her mission centers around the integration of scientific accuracy with human aspirations, continuously pushing the boundaries of innovation in healthcare.

Forbes JAPAN WOMEN AWARD 2025

The Forbes JAPAN WOMEN AWARD is recognized as one of the largest awards in Japan promoting women's empowerment, honoring both individuals and corporations. Yamaguchi’s innovative approach as a researcher and business leader, particularly her long-term commitment to solving social issues, led to her receiving the prestigious ‘Pioneer Award’ in the individual category.

Her commitment to translating scientific expertise into societal benefits, particularly in addressing women's health challenges and pain alleviation, has established her as a role model for many aspiring female researchers and entrepreneurs.

EY Winning Women 2025

Additionally, Yamaguchi has been selected as one of the distinguished women leaders in the EY Winning Women program for her outstanding innovations in business. This recognition not only honors her achievements but also positions her to leverage EY's international network to expand collaborative research and development in AI-based drug discovery.

Yoko Yamaguchi’s Reflections

In her own words, Yamaguchi shared, "From examining molecules in the lab to researching human skin and pain relief, my journey has transformed remarkably. I believe in the moments when science can serve humanity, and I am grateful for this recognition, which reflects my team's efforts and the support of many. Healing someone’s pain through science is my guiding principle, and I will continue to take on new challenges ahead."

Future Perspectives

Looking ahead, Yamaguchi plans to strengthen her role in advocating for women’s leadership through various forums and media appearances. She aims to accelerate global collaboration, particularly in AI-focused drug development, utilizing EY’s overseas networks. Furthermore, she is dedicated to enhancing human capital management by promoting diverse work styles and career support, ensuring sustainable organizational growth.

Nanoegg remains committed to revolutionizing drug discovery technologies originating from medical settings, striving to improve the lives of more people.

About Nanoegg Inc.

Founded in 2006, Nanoegg Inc. operates under the philosophy of being a company that is faithful to its original science. The venture has developed a unique DDS technology and has continuously worked towards creating new value in the fields of medicine, beauty, and prevention through a research-centric team.